Related references
Note: Only part of the references are listed.CNS delivery of l-dopa by a new hybrid glutathione-methionine peptidomimetic prodrug
Francesco Pinnen et al.
AMINO ACIDS (2012)
Molecular mechanism underlying the cerebral effect of Gly-Pro-Glu tripeptide bound to L-dopa in a Parkinson's animal model
Alba Minelli et al.
AMINO ACIDS (2012)
GPE and GPE Analogues as Promising Neuroprotective Agents
I. Cacciatore et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2012)
2,5-Diketopiperazines as Neuroprotective Agents
C. Cornacchia et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2012)
Glutathione depletion and overproduction both initiate degeneration of nigral dopaminergic neurons
Manuel Garrido et al.
ACTA NEUROPATHOLOGICA (2011)
The role of β-amyloid peptide in neurodegenerative diseases
A. V. Maltsev et al.
AGEING RESEARCH REVIEWS (2011)
Ibuprofen and Glutathione Conjugate as a Potential Therapeutic Agent for Treating Alzheimer's Disease
Francesco Pinnen et al.
ARCHIV DER PHARMAZIE (2011)
Hybrid Molecules Incorporating Natural Products: Applications in Cancer Therapy, Neurodegenerative Disorders and Beyond
M. Decker
CURRENT MEDICINAL CHEMISTRY (2011)
Neuroprotective strategies involving ROS in Alzheimer disease
Magali Dumont et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Antioxidant protection: A promising therapeutic intervention in neurodegenerative disease
Nilanjan Ghosh et al.
FREE RADICAL RESEARCH (2011)
The Mitochondria-Targeted Antioxidant MitoQ Prevents Loss of Spatial Memory Retention and Early Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease
Meagan J. McManus et al.
JOURNAL OF NEUROSCIENCE (2011)
Decreased glutathione accelerates neurological deficit and mitochondrial pathology in familial ALS-linked hSOD1G93A mice model
Marcelo R. Vargas et al.
NEUROBIOLOGY OF DISEASE (2011)
Codrug: An efficient approach for drug optimization
N. Das et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases
Moonhee Lee et al.
FASEB JOURNAL (2010)
N-Acetyl-L-Methionyl-L-Dopa-Methyl Ester as a dual acting drug that relieves L-Dopa-induced oxidative toxicity
Alba Minelli et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Basic mechanisms of neurodegeneration: a critical update
Kurt A. Jellinger
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
An overview of liposome lyophilization and its future potential
Chengjun Chen et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Prodrug Approach for Increasing Cellular Glutathione Levels
Ivana Cacciatore et al.
MOLECULES (2010)
Liposomal-Glutathione Provides Maintenance of Intracellular Glutathione and Neuroprotection in Mesencephalic Neuronal Cells
Gail D. Zeevalk et al.
NEUROCHEMICAL RESEARCH (2010)
Glutathione dysregulation and the etiology and progression of human diseases
Nazzareno Ballatori et al.
BIOLOGICAL CHEMISTRY (2009)
Synthesis and Characterization of Poly(ethylene glycol)-Glutathione Conjugate Self-Assembled Nanoparticles for Antioxidant Delivery
Sharlene R. Williams et al.
BIOMACROMOLECULES (2009)
Recent Advances in Medicinal Chemistry and Pharmaceutical Technology-Strategies for Drug Delivery to the Brain
Nunzio Denora et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Glutathione-a review on its role and significance in Parkinson's disease
Heather L. Martin et al.
FASEB JOURNAL (2009)
Characterization of UPF peptides, members of the glutathione analogues library, on the basis of their effects on oxidative stress-related enzymes
Kersti Ehrlich et al.
FREE RADICAL RESEARCH (2009)
Codrugs Linking L-Dopa and Sulfur-Containing Antioxidants: New Pharmacological Tools against Parkinson's Disease
Francesco Pinnen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Aging: An important factor for the pathogenesis of neurodegenerative diseases
Tahira Farooqui et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2009)
Why have antioxidants failed in clinical trials?
Steven R. Steinhubl
AMERICAN JOURNAL OF CARDIOLOGY (2008)
New L-dopa codrugs as potential antiparkinson agents
Piera Sozio et al.
ARCHIV DER PHARMAZIE (2008)
PLGA nanoparticles of different surface properties: Preparation and evaluation of their body distribution
Farnaz Esmaeili et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Design, synthesis and biological evaluation of glutathione peptidomimetics as components of anti-Parkinson prodrugs
Swati S. More et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Toward an optimal blood-brain barrier shuttle by synthesis and evaluation of peptide libraries
Morteza Malakotikhah et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
A novel approach to enhancing cellular glutathione levels
Pamela Maher et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Novel nanomaterials for clinical neuroscience
Jamie L. Gilmore et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2008)
Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons result in nigrostriatal degeneration
Shankar J. Chinta et al.
JOURNAL OF NEUROSCIENCE (2007)
Nanoparticles of hydrophobically modified dextrans as potential drug carrier systems
A. Aumelas et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2007)
Synthesis and study of L-dopa-glutathione codrugs as new anti-parkinson agents with free radical scavenging properties
Francesco Pinnen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease
M. C. Polidori et al.
AMINO ACIDS (2007)
Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: Relevance to Parkinson's disease
G. D. Zeevalk et al.
EXPERIMENTAL NEUROLOGY (2007)
Design, synthesis and properties of novel powerful antioxidants, glutathione analogues
Kersti Ehrlich et al.
FREE RADICAL RESEARCH (2007)
Free radicals and antioxidants in normal physiological functions and human disease
Marian Valko et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: Implications for Parkinson's disease
Shankar J. Chinta et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
Michael T. Lin et al.
NATURE (2006)
Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective
D. Venkat Ratnam et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease
I Guidi et al.
NEUROBIOLOGY OF AGING (2006)
Potent isozyme-selective inhibition of human glutathione S-transferase A1-1 by a novel glutathione S-conjugate
I Cacciatore et al.
AMINO ACIDS (2005)
Conjugation of catechins with cysteine generates antioxidant compounds with enhanced neuroprotective activity
JL Torres et al.
PHYTOCHEMISTRY (2005)
Gender differences in glutathione metabolism in Alzheimer's disease
HL Liu et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Biochemical properties of new synthetic carnosine analogues containing the residue of 2,3-diaminopropionic acid: the effect of N-acetylation
I Cacciatore et al.
AMINO ACIDS (2005)
Transition state isosteres of the γ-glutamyl peptide bond hydrolysis:: Synthesis and characterization of the ψ(CH2NH) pseudopeptide analogue of glutathione
I Cacciatore et al.
JOURNAL OF PEPTIDE SCIENCE (2004)
Recent advances on chitosan-based micro- and nanoparticles in drug delivery
SA Agnihotri et al.
JOURNAL OF CONTROLLED RELEASE (2004)
An antioxidant tetrapeptide UPF1 in rats has a neuroprotective effect in transient global brain ischemia
P Poder et al.
NEUROSCIENCE LETTERS (2004)
Antioxidant effects of sulfur-containing amino acids
G Atmaca
YONSEI MEDICAL JOURNAL (2004)
The importance of glutathione in human disease
DM Townsend et al.
BIOMEDICINE & PHARMACOTHERAPY (2003)
Glutathione pathways in the brain
R Dringen et al.
BIOLOGICAL CHEMISTRY (2003)
Oxidative stress in Parkinson's disease
P Jenner
ANNALS OF NEUROLOGY (2003)
Biochemical and Therapeutic Effects of Antioxidants in the Treatment of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis
Vincenzo Di Matteo et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2003)
Risk factors for Alzheimer's disease: Role of multiple antioxidants, non-steroidal anti-inflammatory and cholinergic agents alone or in combination in prevention and treatment
KN Prasad et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2002)
Antioxidants as treatment for neurodegenerative disorders
B Moosmann et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2002)
Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach
C Behl et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)
Elevated glutathione as a therapeutic strategy in Alzheimer's disease
DA Butterfield et al.
DRUG DEVELOPMENT RESEARCH (2002)
Synthesis and biological evaluation of a novel pyroglutamyl-modified TRH analogue
L Brunetti et al.
FARMACO (2002)
Superoxide dismutase and the death of motoneurons in ALS
JS Beckman et al.
TRENDS IN NEUROSCIENCES (2001)
Chemistry and biochemistry of oxidative stress in neurodegenerative disease
LM Sayre et al.
CURRENT MEDICINAL CHEMISTRY (2001)
Novel roles for glutathione in gene expression, cell death, and membrane transport of organic solutes
CL Hammond et al.
JOURNAL OF HEPATOLOGY (2001)
Mucoadhesive nanoparticulate systems for peptide drug delivery
H Takeuchi et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Metabolism and functions of glutathione in brain
R Dringen
PROGRESS IN NEUROBIOLOGY (2000)
Glutathione, oxidative stress and neurodegeneration
JB Schulz et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Review:: Alzheimer's amyloid β-peptide-associated free radical oxidative stress and neurotoxicity
S Varadarajan et al.
JOURNAL OF STRUCTURAL BIOLOGY (2000)
Share Paper
